14-day Premium Trial Subscription Try For FreeTry Free

Panbela Therapeutics Inc. Stock Insider Power

Based on the 92 latest insides trades, we have calculated the insider power to be positive at 45.63. In total, the insiders bought 2 404 665 and sold 81 291 PBLA shares in the last 92 trades.

Insider Power

(Last 92 transactions)
45.63
Buy 2 404 665 Shares
Sell 81 291 Shares

Historical Insider Trades

Date Type Action Person Amount
Nov 08, 2023 Common Stock Sell Goldman Sachs Group Inc 72 874
Nov 07, 2023 Common Stock Buy Goldman Sachs Group Inc 0
Sep 12, 2023 Common Stock Sell Jacob Jeffrey E. 275
Mar 27, 2023 Stock Option (right to buy) Buy Simpson Jennifer K. 99 383
Mar 27, 2023 Stock Option (right to buy) Buy Horvath Susan 34 369
Mar 27, 2023 Stock Option (right to buy) Buy Cullen Michael T. 8 333
Mar 27, 2023 Stock Option (right to buy) Buy Donovan Daniel 8 333
Mar 27, 2023 Stock Option (right to buy) Buy Fratamico Arthur 8 333
Mar 27, 2023 Stock Option (right to buy) Buy Jacob Jeffrey E. 8 333
Mar 27, 2023 Stock Option (right to buy) Buy Mathiesen Jeffrey S 8 333
Mar 27, 2023 Stock Option (right to buy) Buy Schemel Donald Robert 8 333
Jan 30, 2023 Warrants (right to buy) Buy Simpson Jennifer K. 8 888
Jan 30, 2023 Common Stock Buy Simpson Jennifer K. 4 444
Jan 30, 2023 Common Stock Buy Horvath Susan 4 444
Jan 30, 2023 Warrants (right to buy) Buy Horvath Susan 8 888
Oct 04, 2022 Common Stock Buy Cullen Michael T. 165 000
Oct 04, 2022 Warrants (right to buy) Buy Cullen Michael T. 247 000
Oct 04, 2022 Common Stock Buy Schemel Donald Robert 200 000
Oct 04, 2022 Warrants (right to buy) Buy Schemel Donald Robert 300 000
Oct 04, 2022 Common Stock Buy Jacob Jeffrey E. 33 000
Oct 04, 2022 Warrants (right to buy) Buy Jacob Jeffrey E. 49 500
Jun 15, 2022 Common Stock Buy Jacob Jeffrey E. 0
Jun 15, 2022 Common Stock Buy Jacob Jeffrey E. 0
Jun 15, 2022 Common Stock Buy Jacob Jeffrey E. 0
Jun 15, 2022 Stock Option (right to buy) Buy Jacob Jeffrey E. 41 766
Click to get the best stock tips daily for free!

About Panbela Therapeutics Inc.

Panbela Therapeutics. Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, ... PBLA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT